Columnist Desiree Lama has always known she wanted to help people; now she is achieving that goal through MS advocacy.

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

Vaccination didn't increase the risk of children or adolescents being diagnosed with pediatric MS within five years, a study ...

Nabiximols and other cannabis-based treatments were seen to work well at controlling spasticity, though responses vary among ...

Tiziana's Phase 2 trial testing foralumab for nonactive secondary progressive multiple sclerosis (SPMS) has added six U.S.